EP3528838
Notkun á IL-13 mótlyfjum til meðhöndlunar á ofnæmishúðbólgu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.9.2017EP published:
19.7.2023EP application number:
17780280.8
EP translation filed:
28.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
21.9.2037Expiry date:
21.9.2026Next due date:
30.9.2026
Title in English:
USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITISLanguage of the patent:
English
Timeline
Today
22.9.2017EP application
19.7.2023EP Publication
28.8.2023Translation submitted
15.9.2023Registration published
21.9.2026Expires
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
LIN, ChinYuAddress:
South San Francisco, CA 94080, US
Name:
OMACHI, Theodore A.Address:
South San Francisco, CA 94080, US
Name:
OWEN, Ryan P.Address:
South San Francisco, CA 94080, US
Name:
YEN, KarlAddress:
South San Francisco, CA 94080, US
Name:
ZHENG, YananAddress:
Cupertino, CA 95014, US
Name:
DEBUSK, KendraAddress:
South San Francisco, CA 94080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662398713 PDate:
23.9.2016Country:
US
Number:
201762527204 PDate:
30.6.2017Country:
US
Number:
201762530683 PDate:
10.7.2017Country:
US
Number:
201762539037 PDate:
31.7.2017Country:
US
Supplementary protection
SPC number:
SPC465
Classification
Categories:
A61K 39/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.9.2023
Expires: 21.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.8.2024
Expires: 21.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.9.2025
Expires: 21.9.2026
Payer: Árnason Faktor ehf.